Physician profile
Ashley Althoff
NPI 1497251169
$2,289.37
in general payments reported to CMS, 2019-2025
9 companies · $1,321 in 2025
The $1,321 reported for 2025 was more than what 76% of Colon & Rectal Surgery providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $144 · 2024: $824 · 2025: $1,321.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,869 · Education: $420.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,869.15 |
| Education | $420.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $798.56 | 2025 | |
| Medtronic, INC. | $361.63 | 2024-2025 | Interstim |
| Integra Lifesciences Corporation | $334.84 | 2024-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Rti Surgical, INC | $228.02 | 2024 | |
| Guard Medical INC. | $144.17 | 2023 | Npseal Medium, Npseal Large, Npseal (5) |
| Boston Scientific Corporation | $127.35 | 2024 | |
| Abbvie INC. | $127.32 | 2024 | |
| Conmed Corporation | $96.37 | 2024 | Airseal |
| Becton, Dickinson and Company | $71.11 | 2025 | Hemosphere |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Althoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.